Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.15.6333

Lack of Association between the MTHFR C677T Polymorphism and Lung Cancer in a Turkish Population  

Yilmaz, Meral (Department of Research Centre, Faculty of Medicine, Cumhuriyet University)
Kacan, Turgut (Department of Medical Oncology, Faculty of Medicine, Cumhuriyet University)
Sari, Ismail (Department of Medical Biochemistry, Faculty of Medicine, Cumhuriyet University)
Kilickap, Saadettin (Department of Medical Oncology, Faculty of Medicine, Hacettepe University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.15, 2014 , pp. 6333-6337 More about this Journal
Abstract
Background: In this case-control study, we aimed to investigate the relationship between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and lung cancer. Materials and Methods: Total 200 individuals including 100 patients with lung cancer and 100 controls were analyzed. Genotyping of MTHFR C677T was performed using PCR and RFLP methods. Results: The majority of the patients were men and 90% were smokers. We found that the risk ratio for development of LC was 13-times higher in smokers compared with non-smokers between patient and control groups in our study (OR:13.5, 95%CI:6.27-29.04, p:0.0001). Besides, the risk ratio for development of LC was nine times higher in individuals with cancer history in their family than those without cancer history (OR:9.65, 95%CI: 2.79-33.36; p:0.0001). When genotype distributions and allele frequencies were analyzed in the study groups, no significant difference was apparent (${\chi}^2$:0.53, p=0.76). In addition, no correlation between genotypes of MTHFRC677T polymorphism and histological type of LC was found (${\chi}^2$:0.99, p=0.60). Conclusions: These results suggest that there was no association between the MTHFR C677T polymorphism and lung cancer in the Turkish population.
Keywords
Lung cancer; risk factor; methylenetetrahydrofolate reductase gene; polymorphism;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Liu CS, Tsai CW, Hsia TC, et al (2009). Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics, 6, 325-9.
2 Liu ZB, Wang LP, Shu J, Jin C, Lou ZX (2013). Methylenetetrahydrofolate reductase 677TT genotype might be associated with an increased lung cancer risk in Asians. Gene, 515, 214-9.   DOI   ScienceOn
3 Mao R, Fan Y, Jin Y, Bai J, Fu S (2008). Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a metaanalysis. J Hum Genet, 53, 340-8.   DOI   ScienceOn
4 Matakidou A, El Galta R, Rudd MF, et al (2007). Prognostic significance of folate metabolism polymorphisms for lung cancer. Br J Cancer, 97, 247-52.   DOI   ScienceOn
5 Papandreou CN, Doxani C, Zdoukopoulos N, et al (2012). Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a candidate gene-association study in a South-eastern European population. DNA Cell Biol, 31, 193-8.   DOI
6 Robien K, Ulrich CM (2003). 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol, 157, 571-82.   DOI   ScienceOn
7 Shen H, Spitz MR, Wang LE, Hong WK, Wei Q (2001). Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemol Biomarkers Prev, 10, 397-401.
8 Shen H, Wei Q, Pillow PC, et al (2003). Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol, Biomarkers Prev, 12, 980-6.
9 Siemianowicz K, Gminski J, Garczorz W, et al (2003). Methylenetetrahydrofolate reductase gene C677T and A1298C polymor- phisms in patients with small cell and non-small cell lung cancer. Oncol Rep, 10, 1341-4.
10 Shields PG (2002). Molecular epidemiology of smoking and lung cancer. Oncogene, 21, 6870-6.   DOI
11 Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA: A Cancer J Clin, 63, 11-30.   DOI   ScienceOn
12 Suzuki T, Matsuo K, Hiraki A, et al (2007). Impact of onecarbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis, 28, 1718-25.   DOI   ScienceOn
13 Voorrips LE, Goldbohm RA, Verhoeven DT, et al (2000). Vegetable and fruit consumption and lung cancer risk in the Netherlands Cohort Study on diet and cancer. Cancer Causes Control, 11, 101-15.   DOI
14 Voorrips LE, Goldbohm RA, Brants HA, et al (2000). A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 357-65.
15 Wakelee HA, Chang ET, Gomez SL, et al (2007). Lung cancer incidence in never smokers. J Clin Oncol, 25, 472-8.   DOI   ScienceOn
16 Wu HC, Chang CH, Tsai RY, et al (2010). Significant association of methylenetetrahydrofolate reductase single nucleotide polymorphisms with prostate cancer susceptibility in Taiwan. Anti- Cancer Res, 30, 3573-7.
17 Zhang Y, Chen GQ, Ji Y, et al (2012). Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma. Mol Biol Rep, 39, 6203-11.   DOI   ScienceOn
18 Zhu N, Gong Y, He J, Xia J, Chen X (2013). Influence of methylenetetrahydrofolate reductase C677T polymorphism on the risk of lung cancer and the clinical response to platinum-based chemotherapy for advanced non-small cell lung cancer: an updated meta-analysis. Yonsei Med J, 54, 1384-93.   DOI
19 Izmirli M (2013). A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk. Mol Biol Rep, 40, 625-37.   DOI   ScienceOn
20 Hung RJ, Hashibe M, McKay J, et al (2007). Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis, 28, 1334-40.   DOI   ScienceOn
21 Janssen-Heijnen MLG, Coebergh J-WW (2003). The changing epidemiology of lung cancer in Europe. Lung Cancer, 41, 245-58.   DOI   ScienceOn
22 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: A Cancer J Clin, 61, 69-90.   DOI
23 Jeng YL, Wu MH, Huang HB, et al (2003). The methylenetetrahydrofolate reductase 677C ? T polymorphism and lung cancer risk in a Chinese population. Anticancer Res, 23, 5149-52.
24 Kiyohara C, Horiuchi T, Takayama K, et al (2011). Methylenetetrahydrofolate reductase polymorphisms and interaction with smoking and alcohol consumption in lung cancer risk: a case- control study in a Japanese Population. BMC Cancer, 11, 459.   DOI
25 Krajinovic M, Lamothe S, Labuda D, et al (2004). Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood, 103, 252-7.   DOI   ScienceOn
26 Kwak SY, Kim UK, Cho HJ, et al (2008). Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. Anticancer Res, 28, 2807-11.
27 Levine AJ, Figueiredo JC, Lee W, et al (2010). Genetic variability in the MTHFR gene and colorectal cancer risk using the colorectal cancer family registry. Cancer Epidemiol Biomarkers Prev, 19, 89-100.   DOI
28 Barry AP, Silvestri G, Safrit JT, et al (2007). Depletion of CD8+ cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species. J Immun, 178, 8002-12.   DOI
29 Liu H, Jin G, Wang H, et al (2008). Association of polymorphisms in one-carbon metabolizing genes and lung cancer risk: a case-control study in Chinese population. Lung Cancer, 61, 21-9.   DOI   ScienceOn
30 Arslan S, Karadayi S, Yildirim ME, et al (2011). The association between methylenetetrahydrofolate reductase gene polymorphism and lung cancer risk. Mol Biol Rep, 38, 991-6.   DOI
31 Boccia S, Boffetta P, Brennan P (2009). Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett, 273, 55-61.   DOI   ScienceOn
32 Cheng Z, Wang W, Dai L-L, et al (2012). MTHFR C667T polymorphism association with lung cancer risk in Henan province: a case-control study. Asian Pac J Cancer Prev, 13, 2491-4   과학기술학회마을   DOI
33 Choi SW, Mason JB (2000). Folate and carcinogenesis: an integrated scheme. J Nutr, 130, 129-32.
34 Cui LH, Shin MH, Kim HN, et al (2011). Methylenetetrahydrofolate reductase C677T polymorphism in patients with lung cancer in a Korean population. BMC Med Genet, 12, 28.
35 Duthie SJ (1999). Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull, 55, 578-92.   DOI   ScienceOn
36 Hou XH, Huang YM, Mi YY (2012). Methylenetetrahydrofolate reductase gene C677T polymorphism and lung cancer: an updated meta-analysis. Asian Pac J Cancer Prev, 13, 2025-9.   과학기술학회마을   DOI   ScienceOn
37 Gao S, Ding LH, Wang JW, et al (2013). Diet folate, DNA methylation and polymorphisms in methylenetetrahydrofolate reductase in association with the susceptibility to gastric cancer. Asian Pac J Cancer Prev, 14, 299-302.   과학기술학회마을   DOI
38 Gemignani F, Landi S, Szeszenia-Dabrowska N (2007). Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis, 28, 1287-93.   DOI   ScienceOn
39 Heijmans BT, Boer JM, Suchiman HE (2003). A common variant of the methylenetetrahyrofolate reductase gene (1p36) is associted with an increased risk of cancer. Cancer Res, 63, 1249-53.
40 Mtiraoui N, Zammiti W, Ghazouani L, et al (2006). Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction, 131, 395-401.   DOI